TGen and Kronos initiate Alzheimer’s disease study

Researchers have unprecedented chance to search for Alzheimer’s susceptibility genes and develop advanced clinical testing

Phoenix-Researchers at the Translational Genomics Research Institute (TGen) and Kronos Science Laboratories, an affiliate of Phoenix-based Kronos Optimal Health Company, have initiated a study with unprecedented power to identify genes that are involved in the development of Alzheimer’s disease, the most common form of disabling memory and thinking problems in older persons.

Using cutting edge technology, researchers at TGen will survey 570,000 letters of the genetic alphabet (commonly known as “SNPs”) in the DNA of 1,000 deceased persons confirmed to have Alzheimer’s disease at autopsy and 1,000 deceased persons confirmed to be free of Alzheimer’s disease at autopsy.

Because of the number of SNPs surveyed-more than any surveyed ever before-researchers have an extraordinary opportunity to search for Alzheimer’s susceptibility genes throughout the human genome. “The technology to sift through the human blueprint at ultra-high resolution to get at the root of diseases such as Alzheimer’s has finally come of age,” explains Dietrich A. Stephan, the study’s principal investigator and head of TGen’s Neurogenomics Division. “TGen is one of only a few places in the world that has this type of technology. The collaboration between Kronos and TGen represents a partnership which promises to greatly improve our understanding of the genetic causes of Alzheimer’s disease so we may diagnose it early and develop knowledge-based therapies.”

Kronos Science Laboratories will have an exclusive worldwide license to all intellectual property that results from the research. Based upon the results of this study, Kronos will develop a test that aids in clinical diagnosis and can determine a person’s genetic predisposition for developing Alzheimer’s disease. “An estimated 4.5 million Americans are living with Alzheimer’s disease today, and that number is projected to more than triple by 2050,” said Dr. Christopher Heward, President of Kronos Science Laboratories. “At Kronos, we are passionate about our healthy living and aging philosophy, and we’re pleased to demonstrate this commitment by participating in this unparalleled study that has the potential to make a significant impact in the lives of affected individuals and families.”

To date, researchers have identified several rare genes that cause a form of Alzheimer’s disease resulting in memory and thinking problems before the age of 60. In addition, scientists have identified a common gene that accounts for about 30 percent of those who develop the symptoms of Alzheimer’s disease after the age of 60. The search is now on to discover other genes that contribute to the development of Alzheimer’s disease.

Researchers will obtain DNA samples from brain banks in the USA and Europe.

“We could not be more excited about the possibility of discovering the remaining genes involved in the development of Alzheimer’s disease,” says the study’s other principal investigator, Dr. Eric Reiman, Clinical Director of the Neurogenomics Division at TGen, Director of the Arizona Alzheimer’s Disease Consortium, Professor of Psychiatry at the University of Arizona, and Scientific Director of the Positron Emission Tomography Center at Banner Good Samaritan Medical Center. “We hope that this information will improve our understanding of the disorder, provide targets against which to aim new treatments, and permit health care providers to identify those who might benefit from disease-slowing and prevention therapies at the earliest possible time.”

The study is expected to cost approximately $6 million and will be jointly funded by TGen and Kronos. Researchers expect the study to be completed within 18 months.

Media Contact

Galen Perry EurekAlert!

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors